My SNMMI Overview
MEMBER DIRECTORY
LEARNING CENTER
The purpose of this document is to describe the appropriate use of positron emission tomography-computed tomography (PET/CT) with 18F-fluorodeoxyglcouse (18F-FDG) in the initial staging of malignant disease.
To view the development process, please click the following link: SNMMI AUC Development Process.
Click here to view the Appropriate Use Criteria for 18F-FDG PET/CT for Initial Staging of Malignant Disease